Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GS 9674. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel non-Pd, non-n-BuLi route for Cilofexor intermediates. High purity, scalable process for FXR agonists ensuring supply chain stability.